Caliper Life Sciences (CALP) Posts Q2 EPS of $0.00, Tops Views; Maintains Outlook
Caliper Life Sciences (Nasdaq: CALP) reports Q2 EPS of $0.00, 6 cents better than the analyst estimate of ($0.06). Revenue for the quarter was $29.05 million, which compares to the estimate of $27.80 million. Maintains outlook.
Get Alerted When News Hits On This Stock - FREE!